sign in sign up
<<
Home , Diazoxide, Mabuterol

Chapter 260-70 Chapter 260-70 WAC EQUINE MEDICATION PROGRAM

WAC 12/6/93. Statutory Authority: RCW 67.16.020 and 260-70-500 Definitions applicable to chapter 260-70 WAC. 67.16.040. 84-06-061 (Order 84-01), § 260-70-028, 260-70-510 Equine health and safety. filed 3/7/84.] Repealed by 96-10-001, filed 4/17/96, 260-70-540 Veterinarians' reports. effective 5/18/96. Statutory Authority: RCW 260-70-545 Prohibited practices. 67.16.040. 260-70-550 Medication labeling. 260-70-029 Receiving barn. [Statutory Authority: RCW 67.16.020 260-70-560 Treatment restrictions. and 67.16.040. 84-06-061 (Order 84-01), § 260-70-029, 260-70-570 All horses are subject to inspection. filed 3/7/84.] Repealed by 96-10-001, filed 4/17/96, 260-70-580 Official veterinarian's list. effective 5/18/96. Statutory Authority: RCW 67.16.- 260-70-590 Reporting to the test barn. 040. 260-70-600 Sample collection. 260-70-030 When administration prohibited. [Order 74.1, § 260-70- 260-70-610 Storage and shipment of split samples. 030, filed 5/22/74, effective 7/1/74.] Repealed by 80-01- 260-70-620 Medication restrictions. 072 (Order 79-02), filed 12/24/79. Statutory Authority: 260-70-630 Threshold levels. RCW 67.16.020 and 67.16.040. 260-70-640 Permitted medication. 260-70-031 Reporting to receiving barn. [Statutory Authority: 260-70-645 Anti-ulcer medications. RCW 67.16.020 and 67.16.040. 84-06-061 (Order 84- 260-70-650 . 01), § 260-70-031, filed 3/7/84.] Repealed by 96-10- 260-70-660 Furosemide and bleeder lists. 001, filed 4/17/96, effective 5/18/96. Statutory Author- 260-70-675 Bicarbonate testing. ity: RCW 67.16.040. 260-70-680 Uniform classification guidelines. 260-70-032 Exclusion from receiving and detention barn. [Statutory 260-70-710 Voiding track record. Authority: RCW 67.16.020 and 67.16.040. 84-06-061 260-70-720 Posterior digital neurectomy. (Order 84-01), § 260-70-032, filed 3/7/84.] Repealed by 260-70-730 Postmortem examination. 96-10-001, filed 4/17/96, effective 5/18/96. Statutory Authority: RCW 67.16.040. 260-70-040 Horses to be tested. [Statutory Authority: RCW 67.16.- DISPOSITION OF SECTIONS FORMERLY 040. 94-04-002, § 260-70-040, filed 1/20/94, effective CODIFIED IN THIS CHAPTER 2/20/94. Statutory Authority: RCW 67.16.020 and 67.16.040. 82-07-016 (Order 82-02), § 260-70-040, 260-70-010 Definitions applicable to chapter 260-70 WAC. [Statu- filed 3/9/82; Order 74.1, § 260-70-040, filed 5/22/74, tory Authority: RCW 67.16.020 and 67.16.040. 89-04- effective 7/1/74.] Repealed by 96-10-001, filed 4/17/96, 026 (Order 88-06), § 260-70-010, filed 1/25/89; 87-15- effective 5/18/96. Statutory Authority: RCW 67.16.- 020 (Resolution No. 87-03), § 260-70-010, filed 7/8/87; 040. 86-09-072 (Order 86-02), § 260-70-010, filed 4/21/86; 260-70-050 Procedure for taking specimens. [Statutory Authority: 84-06-061 (Order 84-01), § 260-70-010, filed 3/7/84; RCW 67.16.020 and 67.16.040. 87-15-020 (Resolution Order 75.5, § 260-70-010, filed 10/17/75; Order 74.1, § No. 87-03), § 260-70-050, filed 7/8/87. Statutory 260-70-010, filed 5/22/74, effective 7/1/74.] Repealed Authority: RCW 67.16.020. 78-06-001 (Order 78-1), § by 96-10-001, filed 4/17/96, effective 5/18/96. Statu- 260-70-050, filed 5/4/78; Order 74.1, § 260-70-050, tory Authority: RCW 67.16.040. filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, 260-70-020 Medication permitted—Prohibited. [Statutory Author- filed 4/17/96, effective 5/18/96. Statutory Authority: ity: RCW 67.16.020. 78-06-001 (Order 78-1), § 260- RCW 67.16.040. 70-020, filed 5/4/78; Order 74.1, § 260-70-020, filed 260-70-060 Effect of laboratory analysis. [Statutory Authority: 5/22/74, effective 7/1/74.] Repealed by 80-01-072 RCW 67.16.020. 78-06-001 (Order 78-1), § 260-70- (Order 79-02), filed 12/24/79. Statutory Authority: 060, filed 5/4/78; Order 74.1, § 260-70-060, filed RCW 67.16.020 and 67.16.040. 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed 260-70-021 Medication standards. [Statutory Authority: RCW 4/17/96, effective 5/18/96. Statutory Authority: RCW 67.16.020 and 67.16.040. 87-15-020 (Resolution No. 67.16.040. 87-03), § 260-70-021, filed 7/8/87; 84-06-061 (Order 260-70-070 Persons responsible. [Statutory Authority: RCW 84-01), § 260-70-021, filed 3/7/84; 82-03-053 (Order 67.16.020. 78-06-001 (Order 78-1), § 260-70-070, filed 82-01), § 260-70-021, filed 1/20/82; 80-01-072 (Order 5/4/78; Order 74.1, § 260-70-070, filed 5/22/74, effec- 79-02), § 260-70-021, filed 12/24/79.] Repealed by 96- tive 7/1/74.] Repealed by 96-10-001, filed 4/17/96, 10-001, filed 4/17/96, effective 5/18/96. Statutory effective 5/18/96. Statutory Authority: RCW 67.16.- Authority: RCW 67.16.040. 040. 260-70-025 Bleeder list. [Statutory Authority: RCW 67.16.040. 93- 260-70-080 Procedure upon positive finding by chief chemist. [Stat- 23-009, § 260-70-025, filed 11/5/93, effective 12/6/93. utory Authority: RCW 67.16.020. 78-06-001 (Order Statutory Authority: RCW 67.16.020 and 67.16.040. 78-1), § 260-70-080, filed 5/4/78; Order 74.1, § 260-70- 87-15-020 (Resolution No. 87-03), § 260-70-025, filed 080, filed 5/22/74, effective 7/1/74.] Repealed by 96-10- 7/8/87; 84-06-061 (Order 84-01), § 260-70-025, filed 001, filed 4/17/96, effective 5/18/96. Statutory Author- 3/7/84.] Repealed by 96-10-001, filed 4/17/96, effective ity: RCW 67.16.040. 5/18/96. Statutory Authority: RCW 67.16.040. 260-70-090 Permitted level of approved NSAIDS. [Statutory 260-70-026 Bleeder treatment. [Statutory Authority: RCW 67.16.- Authority: RCW 67.16.020 and 67.16.040. 89-04-026 040. 94-20-070, § 260-70-026, filed 10/3/94, effective (Order 88-06), § 260-70-090, filed 1/25/89; 87-15-020 11/3/94. Statutory Authority: RCW 67.16.020 and (Resolution No. 87-03), § 260-70-090, filed 7/8/87; 84- 67.16.040. 87-15-020 (Resolution No. 87-03), § 260- 06-061 (Order 84-01), § 260-70-090, filed 3/7/84; 80- 70-026, filed 7/8/87; 84-06-061 (Order 84-01), § 260- 05-132 (Order 79-03), § 260-70-090, filed 5/7/80; Order 70-026, filed 3/7/84.] Repealed by 96-10-001, filed 74.1, § 260-70-090, filed 5/22/74, effective 7/1/74.] 4/17/96, effective 5/18/96. Statutory Authority: RCW Repealed by 96-10-001, filed 4/17/96, effective 5/18/96. 67.16.040. Statutory Authority: RCW 67.16.040. 260-70-027 Reciprocity of bleeder list. [Statutory Authority: RCW 260-70-100 Penalties relating to overage of permitted medication. 67.16.020 and 67.16.040. 84-06-061 (Order 84-01), § [Statutory Authority: RCW 67.16.020 and 67.16.040. 260-70-027, filed 3/7/84.] Repealed by 96-10-001, filed 85-12-057 (Order 85-02), § 260-70-100, filed 6/5/85; 4/17/96, effective 5/18/96. Statutory Authority: RCW 84-06-061 (Order 84-01), § 260-70-100, filed 3/7/84; 67.16.040. 83-19-054 (Order 83-04), § 260-70-100, filed 9/19/83; 260-70-028 Detention stall. [Statutory Authority: RCW 67.16.040. 82-03-053 (Order 82-01), § 260-70-100, filed 1/20/82; 93-23-008, § 260-70-028, filed 11/5/93, effective 80-05-132 (Order 79-03), § 260-70-100, filed 5/7/80;

(1/14/11) [Ch. 260-70 WAC—p. 1] 260-70-500 Equine Medication Program

Order 74.1, § 260-70-100, filed 5/22/74, effective filed 4/17/96, effective 5/18/96. Statutory Authority: 7/1/74.] Repealed by 96-10-001, filed 4/17/96, effective RCW 67.16.040. 5/18/96. Statutory Authority: RCW 67.16.040. 260-70-280 Effective date—Repealer. [Order 74.1, § 260-70-280, 260-70-110 Commission may require association to set apart place filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, for medication and testing. [Order 74.1, § 260-70-110, filed 4/17/96, effective 5/18/96. Statutory Authority: filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, RCW 67.16.040. filed 4/17/96, effective 5/18/96. Statutory Authority: 260-70-290 Reporting to receiving barn. [Statutory Authority: RCW 67.16.040. RCW 67.16.020 and 67.16.040. 82-09-016 (Order 82- 260-70-120 Sampling medications and drugs. [Statutory Authority: 03), § 260-70-290, filed 4/9/82.] Repealed by 96-10- RCW 67.16.020 and 67.16.040. 87-15-020 (Resolution 001, filed 4/17/96, effective 5/18/96. Statutory Author- No. 87-03), § 260-70-120, filed 7/8/87; Order 74.1, § ity: RCW 67.16.040. 260-70-120, filed 5/22/74, effective 7/1/74.] Repealed 260-70-300 Exclusion from receiving barn. [Statutory Authority: by 96-10-001, filed 4/17/96, effective 5/18/96. Statu- RCW 67.16.020 and 67.16.040. 82-09-016 (Order 82- tory Authority: RCW 67.16.040. 03), § 260-70-300, filed 4/9/82.] Repealed by 96-10- 260-70-130 Voiding track record. [Order 74.1, § 260-70-130, filed 001, filed 4/17/96, effective 5/18/96. Statutory Author- 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed ity: RCW 67.16.040. 4/17/96, effective 5/18/96. Statutory Authority: RCW 260-70-520 Trainer responsibility. [Statutory Authority: RCW 67.16.040. 67.16.020 and 67.16.040. 06-09-009, § 260-70-520, 260-70-140 Hypodermic instruments. [Statutory Authority: RCW filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70- 67.16.020 and 67.16.040. 81-09-075 (Order 81-03), § 520, filed 3/11/05, effective 4/11/05. Statutory Author- 260-70-140, filed 4/22/81; Order 74.1, § 260-70-140, ity: RCW 67.16.040. 96-10-001, § 260-70-520, filed filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, 4/17/96, effective 5/18/96.] Repealed by 07-03-065, filed 4/17/96, effective 5/18/96. Statutory Authority: filed 1/16/07, effective 2/16/07. Statutory Authority: RCW 67.16.040. RCW 67.16.020. 260-70-150 Who may administer medications. [Order 74.1, § 260- 260-70-530 Veterinarians under authority of official veterinarian. 70-150, filed 5/22/74, effective 7/1/74.] Repealed by 96- [Statutory Authority: RCW 67.16.020 and 67.16.040. 10-001, filed 4/17/96, effective 5/18/96. Statutory 06-09-009, § 260-70-530, filed 4/10/06, effective Authority: RCW 67.16.040. 5/11/06; 05-07-067, § 260-70-530, filed 3/11/05, effec- 260-70-160 Veterinarians under the supervision of state veterinar- tive 4/11/05. Statutory Authority: RCW 67.16.040. 96- ian—Test barn veterinarian. [Order 74.1, § 260-70-160, 10-001, § 260-70-530, filed 4/17/96, effective 5/18/96.] filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, Repealed by 07-07-036, filed 3/12/07, effective 4/12/07. filed 4/17/96, effective 5/18/96. Statutory Authority: Statutory Authority: RCW 67.16.020 and 67.16.040. RCW 67.16.040. 260-70-670 Penalties—Guidelines. [Statutory Authority: RCW 260-70-170 Veterinarian report. [Statutory Authority: RCW 67.16.- 67.16.040. 96-10-001, § 260-70-670, filed 4/17/96, 020 and 67.16.040. 87-15-020 (Resolution No. 87-03), § effective 5/18/96.] Repealed by 05-07-067, filed 260-70-170, filed 7/8/87; 80-05-132 (Order 79-03), § 3/11/05, effective 4/11/05. Statutory Authority: RCW 260-70-170, filed 5/7/80. Statutory Authority: RCW 67.16.020 and 67.16.040. 67.16.020. 78-06-001 (Order 78-1), § 260-70-170, filed 260-70-690 Penalty recommendations (in the absence of mitigating 5/4/78; Order 74.1, § 296-70-170, filed 5/22/74, effec- circumstances). [Statutory Authority: RCW 67.16.040. tive 7/1/74.] Repealed by 96-10-001, filed 4/17/96, 96-10-001, § 260-70-690, filed 4/17/96, effective effective 5/18/96. Statutory Authority: RCW 67.16.- 5/18/96.] Repealed by 05-07-067, filed 3/11/05, effec- 040. tive 4/11/05. Statutory Authority: RCW 67.16.020 and 260-70-180 Improper medication. [Order 74.1, § 260-70-180, filed 67.16.040. 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed 260-70-700 Penalties relating to permitted medication. [Statutory 4/17/96, effective 5/18/96. Statutory Authority: RCW Authority: RCW 67.16.020. 03-06-004, § 260-70-700, 67.16.040. filed 2/20/03, effective 3/23/03. Statutory Authority: 260-70-190 Blocking of legs or ankles. [Order 74.1, § 260-70-190, RCW 67.16.040. 00-07-042, § 260-70-700, filed 3/6/00, filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, effective 4/6/00; 96-10-001, § 260-70-700, filed filed 4/17/96, effective 5/18/96. Statutory Authority: 4/17/96, effective 5/18/96.] Repealed by 05-07-067, RCW 67.16.040. filed 3/11/05, effective 4/11/05. Statutory Authority: 260-70-200 Bandages. [Statutory Authority: RCW 67.16.020 and RCW 67.16.020 and 67.16.040. 67.16.040. 82-09-016 (Order 82-03), § 260-70-200, filed 4/9/82. Statutory Authority: RCW 67.16.020. 78- 06-001 (Order 78-1), § 260-70-200, filed 5/4/78; Order WAC260-70-500 260-70-500 Definitions applicable to chapter 74.1, § 260-70-200, filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed 4/17/96, effective 5/18/96. 260-70 WAC. (1) "Interfering substance" or "interfere" Statutory Authority: RCW 67.16.040. means and refers to any medication which might mask or 260-70-210 Nerving. [Order 74.1, § 260-70-210, filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed 4/17/96, screen the presence of prohibited drugs or prevent testing effective 5/18/96. Statutory Authority: RCW 67.16.- procedures from detecting a prohibited drug. 040. (2) "Post time" means the time set for the arrival of the 260-70-220 Posterior digital neurectomy. [Order 74.1, § 260-70- 220, filed 5/22/74, effective 7/1/74.] Repealed by 96-10- horses at the starting point in a race as specified in writing 001, filed 4/17/96, effective 5/18/96. Statutory Author- and posted by the board of stewards. ity: RCW 67.16.040. 260-70-230 List of nerved horses. [Order 74.1, § 260-70-230, filed [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed 500, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-500, filed 4/17/96, effective 5/18/96. Statutory Authority: RCW 4/10/06, effective 5/11/06. Statutory Authority: RCW 67.16.040. 96-10- 67.16.040. 001, § 260-70-500, filed 4/17/96, effective 5/18/96.] 260-70-240 Examination required. [Order 74.1, § 260-70-240, filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed 4/17/96, effective 5/18/96. Statutory Authority: RCW WAC260-70-510 260-70-510 Equine health and safety. The pur- 67.16.040. pose of this chapter is to protect the integrity of horse racing, 260-70-250 Medication procedures and related instructions. [Order 74.1, § 260-70-250, filed 5/22/74, effective 7/1/74.] to ensure the health and welfare of horses under the jurisdic- Repealed by 96-10-001, filed 4/17/96, effective 5/18/96. tion of the commission, and to safeguard the interests of the Statutory Authority: RCW 67.16.040. 260-70-260 Adulteration of sample. [Order 74.1, § 260-70-260, filed public and the participants in racing. The commission will 5/22/74, effective 7/1/74.] Repealed by 96-10-001, filed hold an annual public meeting, to review veterinarian prac- 4/17/96, effective 5/18/96. Statutory Authority: RCW tices, equine health and medication. This meeting will 67.16.040. 260-70-270 Labelling of medications. [Order 74.1, § 260-70-270, include: filed 5/22/74, effective 7/1/74.] Repealed by 96-10-001, (1) An annual report from an official veterinarian. [Ch. 260-70 WAC—p. 2] (1/14/11) Equine Medication Program 260-70-560

(2) Presentation of data regarding equine medication and (b) Extracorporeal Shock Wave Therapy or Radial Pulse treatment, including a review of the commission's quantita- Wave Therapy machines may only be used by veterinarians tive medication levels and any recommendations for modifi- licensed by the commission; cations. (c) The practicing veterinarian has filed a report with an (3) Public comment regarding equine health and safety, official veterinarian notifying the commission that an Extra- medication and veterinarian practices. corporeal Shock Wave Therapy or Radial Pulse Wave Ther- [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- apy machine is on association grounds; 510, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-510, filed (d) All Extracorporeal Shock Wave Therapy or Radial 4/10/06, effective 5/11/06. Statutory Authority: RCW 67.16.040. 96-10- Pulse Wave Therapy treatments are reported to an official 001, § 260-70-510, filed 4/17/96, effective 5/18/96.] veterinarian on the prescribed form not later than twenty-four hours after treatment. 260-70-540 WAC 260-70-540 Veterinarians' reports. (1) Every (5) The use of a naso gastric tube (a tube longer than six veterinarian who treats a racehorse at any location under the inches) for the administration of any substance within jurisdiction of the commission must, on a form approved by twenty-four hours prior to the post time of the race in which the commission, report all treatment to an official veterinar- the horse is entered and without the prior approval of an offi- ian. The report must include the following: cial veterinarian. (a) The name of the horse treated; [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- (b) The name of any medication, drug, or substance 545, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-545, filed administered or prescribed; 4/10/06, effective 5/11/06; 05-07-067, § 260-70-545, filed 3/11/05, effective (c) The procedure administered; 4/11/05. Statutory Authority: RCW 67.16.020. 04-05-094, § 260-70-545, (d) The name of the trainer; filed 2/18/04, effective 3/20/04.] (e) The date and time of treatment; and 260-70-550 (f) Any other information required by the official veteri- WAC 260-70-550 Medication labeling. (1) No person, narian. excluding licensed veterinarians, may possess any drug, med- (2) The practicing veterinarian must sign the report and ication, chemical, foreign substance or other substance unless file the report with an official veterinarian no later than post the product is labeled as required by this rule. time of the race for which the horse is entered. If the horse is (2) Only medications and drugs prescribed or dispensed not entered to run in a race, the report must be filed with an by a veterinarian licensed to practice veterinary medicine in official veterinarian within forty-eight hours of treatment. this jurisdiction may be on the grounds of a racing association (3) A timely and accurate treatment report may be con- during its licensed race meet or training periods. All medica- sidered by the stewards or the commission as a mitigating tions must have a prescription label attached with the follow- factor when determining the penalty for violation of these ing: rules. (a) The name of the product; [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- (b) The name, address and telephone number of the vet- 540, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-540, filed erinarian prescribing or dispensing the product; 4/10/06, effective 5/11/06; 05-07-067, § 260-70-540, filed 3/11/05, effective (c) The name of each horse (patient) the product is 4/11/05. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-540, intended/ prescribed; filed 4/17/96, effective 5/18/96.] (d) The dose, dosage, duration of treatment and expira-

260-70-545 tion date of the prescribed/ dispensed product; and WAC 260-70-545 Prohibited practices. The following are prohibited practices: (e) The name of the trainer or owner to whom the prod- uct was dispensed. (1) The possession or use of any drug, substance, or medication if the use may endanger the health or welfare of [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 550, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-550, filed the horse or endanger the safety of the rider, or which may 4/10/06, effective 5/11/06; 05-07-067, § 260-70-550, filed 3/11/05, effective adversely affect the integrity of racing; or 4/11/05. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-550, (2) The possession or use of a drug or medication on the filed 4/17/96, effective 5/18/96.] premises of a facility under the jurisdiction of the commis- sion that has not been approved by the United States Food WAC260-70-560 260-70-560 Treatment restrictions. (1) Except and Drug Administration (FDA) for any use in human or ani- as otherwise provided by this section, no person other than a mal, or any substance forbidden by an official veterinarian. veterinarian licensed to practice veterinary medicine in this (3) The possession and/or use of blood doping agents, jurisdiction and licensed by the commission may administer including, but not limited to, those listed below, on the prem- a prescription or controlled medication, drug, chemical or ises of a facility under the jurisdiction of the commission: other substance (including any medication, drug, chemical or (a) Erythropoietin other substance by injection) to a horse at any location under (b) Darbepoietin the jurisdiction of the commission. (c) Oxyglobin (2) Persons not licensed as veterinarians may administer (d) Hemopure the following substances, provided that, in post race testing (4) Extracorporeal Shock Wave Therapy or Radial Pulse the substances do not exceed approved quantitative levels, Wave Therapy unless the following conditions are met: and the substances do not interfere with post race testing: (a) Any treated horse may not race for a minimum of ten (a) A recognized nutritional supplement or other sub- days following treatment; stance, except that any such supplements or substances that (1/14/11) [Ch. 260-70 WAC—p. 3] 260-70-570 Equine Medication Program have been disapproved by an official veterinarian may not be (2) A horse may be removed from the veterinarian's list administered; when an official veterinarian determines the horse is capable (b) A substance given at the direction of or by a prescrip- of competing in a race. tion issued by a licensed veterinarian; or (a) Horses placed on the veterinarian's list that are (c) A nonprescription medication or substance. required to work prior to being removed from the list will (3) No person, other than a licensed veterinarian, may remain on the list for a minimum of ten days. (For purposes possess a hypodermic needle, syringe or device used for of counting days, the first day is the day the horse is placed on intravenous or intramuscular injections on the grounds, the veterinarian's list.) unless approved by the stewards. On all grounds under the (b) Horses that must work to be removed from the veter- jurisdiction of the commission, veterinarians may use only inary list due to soreness, lameness, or certain injuries will be onetime disposable needles, and shall dispose of them in a allowed to work no sooner than the eleventh day after being manner approved by the department of health. placed on the list. (4) A person who has a medical condition requiring the (i) Works should be scheduled with an official veterinar- use of a hypodermic needle, syringe or other device used for ian twenty-four hours in advance. intravenous or intramuscular injections must possess a valid (ii) Horses must work a minimum distance to be deter- prescription issued by a physician licensed to practice medi- mined by an official veterinarian in a time comparable for the cine and prescribe medication. Such a person must control track condition that day. the storage and use of these devices and may be held account- (iii) A blood test will be taken by an official veterinarian able for any unauthorized use. Any person possessing a hypo- following the workout and medications levels may not dermic needle or syringe without a valid prescription may be exceed permitted post-race levels. removed from the grounds. (c) Horses placed on the veterinarian's list that are not (5) Veterinarians may not treat or administer medication required to work may not race for a minimum of thirteen days or drugs to any horse on a race day before the post time for from the date placed on the list. (For purposes of counting the race the horse is entered to run, except for the administra- days, the first day is the day the horse is placed on the veteri- tion of furosemide under the guidelines set forth in WAC narian's list.) 260-70-650, unless first approved by an official veterinarian. [Statutory Authority: RCW 67.16.020. 11-03-052, § 260-70-580, filed [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 1/14/11, effective 2/14/11. Statutory Authority: RCW 67.16.020 and 560, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-560, filed 67.16.040. 07-07-036, § 260-70-580, filed 3/12/07, effective 4/12/07; 06-09- 4/10/06, effective 5/11/06; 05-07-067, § 260-70-560, filed 3/11/05, effective 009, § 260-70-580, filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70- 4/11/05. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-560, 580, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. filed 4/17/96, effective 5/18/96.] 96-10-001, § 260-70-580, filed 4/17/96, effective 5/18/96.]

260-70-590 WAC260-70-570 260-70-570 All horses are subject to inspec- WAC 260-70-590 Reporting to the test barn. (1) The tion. All horses at locations under the jurisdiction of the com- official winning horse and any other horse ordered by the mission are subject to inspections at the discretion of the stewards, official veterinarian or the commission must be stewards or an official veterinarian. taken to the test barn to have a blood and/or urine sample (1) The trainer of each horse or a representative of the taken at the direction of an official veterinarian. trainer must present the horse for inspection as required by an (2) Random or extra testing may be required by the stew- official veterinarian. ards, an official veterinarian, or the commission at any time (2) The assessment of a horse's racing condition will be on any horse on association grounds. based on the recommendations of the American Association (3) A horse selected for testing must be taken directly to of Equine Practitioners and may include: the test barn, unless otherwise directed by the stewards or an (a) Proper identification of the horse; official veterinarian. (b) Observation of each horse in motion; (4) Only persons currently licensed by the commission (c) Manual palpation when indicated; may enter the test barn on a race day. Licensees must have a (d) Close observation in the paddock and saddling area, valid reason for being in the test barn, and may be required to during the parade to post and at the starting gate; and display their license. When accompanying a horse to the test (e) Any other inspection deemed necessary by an official barn no more than three licensees will be permitted to enter veterinarian. the test barn. (3) An official veterinarian will maintain a continuing [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- health and racing soundness record of each horse inspected. 590, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-590, filed 4/10/06, effective 5/11/06. Statutory Authority: RCW 67.16.040. 96-10- [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 001, § 260-70-590, filed 4/17/96, effective 5/18/96.] 570, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-570, filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70-570, filed 3/11/05, effective 260-70-600 4/11/05. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-570, WAC 260-70-600 Sample collection. (1) Sample col- filed 4/17/96, effective 5/18/96.] lection shall be done in accordance with guidelines and instructions provided by official veterinarians. WAC260-70-580 260-70-580 Official veterinarian's list. (1) An (2) An official veterinarian shall determine a minimum official veterinarian will maintain a list of all horses deter- sample requirement for the primary testing laboratory. mined by an official veterinarian to be unfit to compete in a (a) If the specimen obtained from a horse is less than the race due to illness, physical distress, unsoundness, infirmity minimum sample requirement, the entire specimen shall be or other medical condition. sent to the primary testing laboratory. [Ch. 260-70 WAC—p. 4] (1/14/11) Equine Medication Program 260-70-610

(b) If a specimen obtained is greater than the minimum seventy-two hours of the delivery of the request for testing to sample requirement but less than twice that amount, the por- the stewards. tion of the sample that is greater than the minimum sample (3) The owner or trainer requesting testing of a split sam- requirement shall be secured as the split sample. ple is responsible for the cost of shipping and testing. A split (c) If a specimen obtained is greater than twice the mini- sample must be removed from the split sample freezer, and mum sample requirement, a portion of the sample approxi- packaged for shipment by an official veterinarian or designee mately equal to the amount provided for the primary testing in the presence of the owner, trainer, or designee. Failure of laboratory shall be secured as the split sample. the owner, trainer or designee to appear at the time and place (d) Blood samples must be collected at a consistent time, designated by an official veterinarian to package the split preferably not later than one hour post-race. sample for shipping will constitute a waiver of all rights to (e) At Class C race tracks the splitting of samples will be split sample testing. Prior to shipment, the split sample labo- conducted by the primary testing laboratory. ratory's willingness to provide the testing requested and to [Statutory Authority: RCW 67.16.020 and 67.16.040. 05-07-067, § 260-70- send results to both the person requesting the testing and the 600, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. commission, must be confirmed by an official veterinarian. 96-10-001, § 260-70-600, filed 4/17/96, effective 5/18/96.] Arrangements for payment satisfactory to the split sample laboratory must also be confirmed by the owner or trainer. A WAC260-70-610 260-70-610 Storage and shipment of split sam- laboratory for the testing of a split sample must be approved ples. (1) Split samples obtained in accordance with WAC by the commission. The commission will maintain a list of 260-70-600 (2)(b) and (c) will be secured and made available laboratories approved for testing of split samples. for further testing in accordance with the following proce- (4) Prior to opening the split sample freezer, the commis- dures: sion must provide a split sample chain of custody verification (a) A split sample must be secured in the test barn in the form. The split sample chain of custody verification form same manner as the primary sample acquired for shipment to must be completed and signed by the representatives of the a primary laboratory. The split samples will be stored until commission and the owner, trainer or designee. A commis- the primary samples are packed and secured for shipment to sion representative will keep the original and provide a copy the primary laboratory. Split samples will then be transferred to the owner, trainer or designee. to a freezer at a secure location approved by the executive The split sample chain of custody verification form must secretary. include the following: (b) A freezer used to store split samples will be closed (a) The date and time the sample is removed from the and locked at all times except as specifically provided by split sample freezer; these rules. (b) The sample number; (c) A freezer for storage of split samples may only be (c) The address where the split sample is to be sent; opened to deposit or remove split samples, for inventory, or (d) The name of the carrier and the address where the for checking the condition of samples. sample is to be taken for shipment; (d) An official veterinarian will maintain a split sample log that must be used each time a split sample freezer is (e) Verification of retrieval of the split sample from the opened. The log will record the following: freezer; (i) The name of the person opening the split sample (f) Verification of each specific step of the split sample freezer; packaging in accordance with the recommended procedure; (ii) The purpose for opening the freezer; (g) Verification of the address of the split sample labora- (iii) The split samples deposited or removed from the tory on the split sample package; freezer; (h) Verification of the condition of the split sample pack- (iv) The date and time the freezer was opened; age immediately prior to transfer of custody to the carrier; (v) The time the freezer was closed; and and (vi) A notation verifying that the lock was secured after (i) The date and time custody of the sample is transferred the freezer was closed. to the carrier. (e) If at any time it is discovered that the split sample (j) The split sample chain of custody verification form freezer failed or samples were discovered not in a frozen con- must be signed by both the owner's representative and an offi- dition, an official veterinarian must document this discovery cial veterinarian or designee to confirm the packaging of the on the split sample freezer log and immediately report this to split sample. the executive secretary. (5) The exterior of the package must be secured and (2) A trainer or owner of a horse having been notified identified with initialed tape, evidence tape or other means to that a written report from a primary laboratory states that a prevent tampering with the package. The owner, trainer or substance has been found in a specimen obtained pursuant to designee may inspect the package containing the split sample these rules may request that a split sample corresponding to immediately prior to transfer to the delivery carrier to verify the portion of the specimen tested by the primary laboratory that the package is intact and has not been tampered with. be sent to another laboratory approved by the commission. (6) The package containing the split sample will be The request must be made in writing and delivered to the transported to the location where custody is transferred to the stewards not later than forty-eight hours after the trainer of delivery carrier charged with delivery of the package to the the horse receives written notice of the findings of the pri- commission approved laboratory selected by the owner or mary laboratory. The split sample must be shipped within trainer. (1/14/11) [Ch. 260-70 WAC—p. 5] 260-70-620 Equine Medication Program

[Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- found in a horse. The following substances are permissible in 610, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-610, filed test samples up to the stated concentrations: 4/10/06, effective 5/11/06; 05-07-067, § 260-70-610, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.020. 03-11-018, § 260-70-610, Caffeine - 100 ng/ml serum or plasma filed 5/12/03, effective 6/12/03. Statutory Authority: RCW 67.16.040. 96- Benzoylecgonine - 50 ng/ml urine 10-001, § 260-70-610, filed 4/17/96, effective 5/18/96.] Morphine Glucuronides - 50 ng/ml urine (b) If a preponderance of evidence presented shows that 260-70-620 WAC 260-70-620 Medication restrictions. (1) A find- a positive test is the result of environmental substance or ing by the commission approved laboratory of a prohibited inadvertent exposure due to human drug use, that evidence drug, chemical or other substance in a test specimen of a should be considered as a mitigating factor in any disciplin- horse is prima facie evidence that the prohibited drug, chem- ary action taken against the trainer. ical or other substance was administered to the horse and, in (3) Androgenic-anabolic steroids. the case of a post-race test, was present in the horse's body (a) The following androgenic-anabolic steroids are per- while it was participating in a race. Prohibited substances missible in test samples up to the stated concentrations: include: Stanozolol (Winstrol) - 1 ng/ml urine in all horses (a) Drugs or medications for which no acceptable thresh- regardless of sex. old concentration has been established; Boldenone (Equipoise) - 15 ng/ml urine in intact males. (b) Therapeutic medications in excess of established No level is permitted in geldings, fillies or mares. threshold concentrations; Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fil- (c) Substances present in the horse in excess of concen- lies, and mares, and for nandrolone metabolite (5a-oestrane- trations at which such substances could occur naturally; and β (d) Substances foreign to a horse at concentrations that 3 ,17a-diol) - 45 ng/ml urine in intact males. cause interference with testing procedures. Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine (2) Except as otherwise provided by this chapter, a per- in fillies and mares. Samples from intact males will not be son may not administer or cause to be administered to a horse tested for the presence of testosterone. by any means, a prohibited drug, medication, chemical or (b) All other androgenic-anabolic steroids are prohibited other substance, including any restricted medication pursuant in race horses. to this chapter during the twenty-four hour period before post [Statutory Authority: RCW 67.16.020 and 67.16.040. 08-17-051, § 260-70- time for the race in which the horse is entered. 630, filed 8/14/08, effective 9/14/08; 08-05-091, § 260-70-630, filed 2/15/08, effective 6/1/08; 06-09-009, § 260-70-630, filed 4/10/06, effective [Statutory Authority: RCW 67.16.020 and 67.16.040. 06-09-009, § 260-70- 5/11/06; 05-07-067, § 260-70-630, filed 3/11/05, effective 4/11/05. Statutory 620, filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70-620, filed Authority: RCW 67.16.020. 04-05-095, § 260-70-630, filed 2/18/04, effec- 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. 96-10- tive 3/20/04; 03-11-019, § 260-70-630, filed 5/12/03, effective 6/12/03. Stat- 001, § 260-70-620, filed 4/17/96, effective 5/18/96.] utory Authority: RCW 67.16.040. 96-10-001, § 260-70-630, filed 4/17/96, effective 5/18/96.] WAC260-70-630 260-70-630 Threshold levels. (1) Permitted medications. WAC260-70-640 260-70-640 Permitted medication. Trainers (a) The following quantitative medications are permissi- using permitted medication in the care of their horses are sub- ble in test samples up to the stated concentrations: ject to all rules governing such medications. Failure to - 25 ng/ml urine administer permitted medication to a horse on a program of - 50 ng/ml urine permitted medication is a violation of these rules. - 10 ng/ml urine (1) The use of one of three approved nonsteroidal anti- - 50 ng/ml urine inflammatory drugs (NSAIDs) is permitted under the follow- - 5 ng/ml urine ing conditions: - 25 pg/ml serum or plasma (a) The drug may not exceed the following permitted Acepromazine - 25 ng/ml urine serum or plasma threshold concentrations, which are consis- - 25 ng/ml urine tent with administration by a single intravenous injection at Salicylates - 750,000 ng/ml urine least twenty-four hours before the post time for the race in Albuterol - 1 ng/ml urine which the horse is entered: Pyrilamine - 50 ng/ml urine (i) Phenylbutazone - 5 micrograms per milliliter; Theobromine - 2000 ng/ml urine (ii) Flunixin - 50 nanograms per milliliter; (b) The official urine or blood test sample may not con- (iii) Ketoprofen - 10 nanograms per milliliter. tain more than one of the above substances, including their (b) No NSAID, including the approved NSAIDs listed in metabolites or analogs, and may not exceed the concentra- this rule, may be administered within the twenty-four hours tions established in this rule. before post time for the race in which the horse is entered. (2) Environmental substances. (c) The presence of more than one of the three approved (a) Certain substances can be considered "environmen- NSAIDs, with the exception of phenylbutazone in a concen- tal" in that they are endogenous to the horse or that they can tration below 1 microgram per milliliter of serum or plasma arise from plants traditionally grazed or harvested as equine or any unapproved NSAID in the post-race serum or plasma feed or are present in equine feed because of contamination sample is not permitted. The use of all but one of the or exposure during the cultivation, processing, treatment, approved NSAIDs must be discontinued at least forty-eight storage, or transportation phases. Certain drugs are recog- hours before the post time for the race in which the horse is nized as substances of human use and could therefore be entered. [Ch. 260-70 WAC—p. 6] (1/14/11) Equine Medication Program 260-70-660

(2) Any horse to which a NSAID has been administered (ii) Quantitation of furosemide in serum or plasma must is subject to having a blood and/or urine sample(s) taken at be performed when the specific gravity of the corresponding the direction of an official veterinarian to determine the quan- urine sample is not measured or if measured below 1.010. titative NSAID level(s) and/or the presence of other drugs Concentrations may not exceed 100 nanograms of furose- which may be present in the blood or urine sample(s). mide per milliliter of serum or plasma. [Statutory Authority: RCW 67.16.020 and 67.16.040. 08-09-044, § 260-70- [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 640, filed 4/10/08, effective 5/11/08; 07-07-036, § 260-70-640, filed 650, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-650, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-640, filed 4/10/06, effective 4/10/06, effective 5/11/06; 05-07-067, § 260-70-650, filed 3/11/05, effective 5/11/06; 05-07-067, § 260-70-640, filed 3/11/05, effective 4/11/05. Statutory 4/11/05. Statutory Authority: RCW 67.16.020. 03-06-004, § 260-70-650, Authority: RCW 67.16.040. 96-10-001, § 260-70-640, filed 4/17/96, effec- filed 2/20/03, effective 3/23/03. Statutory Authority: RCW 67.16.040. 02- tive 5/18/96.] 10-102, § 260-70-650, filed 4/30/02, effective 5/31/02; 96-10-001, § 260-70- 650, filed 4/17/96, effective 5/18/96.] WAC260-70-645 260-70-645 Anti-ulcer medications. The fol- 260-70-660 lowing anti-ulcer medications are permitted to be adminis- WAC 260-70-660 Furosemide and bleeder lists. The tered, at the stated dosage, up to twenty-four hours prior to official veterinarians will maintain a furosemide list and a the race in which the horse is entered. bleeder list of all horses eligible to race with furosemide. The (1) Cimetidine (Tagamet®) - 8-20 mg/kg PO BID - TID list is a statewide list that applies to all licensed associations. (2) Omeprazole (Gastrogard®) - 2.2 grams PO SID (1) Furosemide list. (3) Ranitidine (Zantac®) - 8 mg/kg PO BID (a) A horse is eligible to race with furosemide if the [Statutory Authority: RCW 67.16.020 and 67.16.040. 06-09-009, § 260-70- licensed trainer and/or veterinarian determine that it would be 645, filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70-645, filed in the horse's best interests to race with furosemide. Notifica- 3/11/05, effective 4/11/05.] tion using prescribed commission forms must be given to an official veterinarian prior to the close of entries to ensure WAC260-70-650 260-70-650 Furosemide. (1) Furosemide may be public notification. administered intravenously to a horse which is entered to (b) If an official veterinarian so orders, a horse placed on compete in a race. Except under the instructions of an official the furosemide list will be placed in detention in its regularly veterinarian for the purpose of removing a horse from the vet- assigned stall, no later than four hours prior to the scheduled erinarian's list or to facilitate the collection of a urine sample, post time for any race in which it is entered to start, and with furosemide will be permitted only after an official veterinar- oral or written notification to the trainer may be watched by ian has placed the horse on the furosemide or bleeder list. commission staff. Once placed in detention, a horse must (2) The use of furosemide is permitted under the follow- remain in its barn or on its assigned hotwalker until it is taken ing circumstances: to the receiving barn or to the paddock to be saddled for the (a) Furosemide must be administered on the grounds of race, except that the stewards may permit a horse to leave the association, by a single intravenous injection, prior to detention to engage in exercise blowouts or warm-up heats. post time for the race for which the horse is entered. (c) The confirmation of a horse eligible to race with furo- (b) The furosemide dosage administered must not semide must be certified in writing by an official veterinarian exceed 500 mg nor be less than 150 mg. and entered on the furosemide list. Copies of the certification (c) The trainer of the treated horse must deliver to an will be issued to the owner of the horse or the owner's desig- official veterinarian or his/her designee no later than one hour nee upon request. prior to post time for the race for which the horse is entered (d) Every horse eligible to race with furosemide, regard- the following information under oath on a form provided by less of age, will be placed on the furosemide list. the commission: (e) A horse placed on the official furosemide list must (i) The name of the horse, the horse's tattoo number, remain on that list unless the licensed trainer and/or veteri- racetrack name, the date and time the furosemide was admin- narian submit(s) a written request to remove the horse from istered to the entered horse; the list. The request must be on commissioned-approved (ii) The dosage amount of furosemide administered to forms and must be submitted to an official veterinarian no the entered horse; and later than time of entry. After a horse has been removed from (iii) The printed name and signature of the attending the furosemide list, the horse may not be placed back on the licensed veterinarian who administered the furosemide. list for a period of sixty calendar days unless determined to be (iv) The signature of the trainer or his/her representative. detrimental to the welfare of the horse, in consultation with (d) Failure to administer furosemide in accordance with an official veterinarian. If a horse is removed from the offi- these rules may result in the horse being scratched from the cial furosemide list a second time in a three hundred sixty- race by the stewards. five day period, the horse may not be placed back on the list (e) Test results must show a detectable concentration of for a period of ninety calendar days. the drug in the post-race serum, plasma or urine sample. (2) Bleeder list. (i) The specific gravity of post-race urine samples may (a) An official veterinarian will maintain a bleeder list of be measured to ensure that samples are sufficiently concen- all horses, which have demonstrated external evidence of trated for proper chemical analysis. The specific gravity must exercise induced pulmonary hemorrhage from one or both not be below 1.010. If the specific gravity of the urine is nostrils during or after a race or workout as observed by an found to be below 1.010 or if a urine sample is unavailable official veterinarian. for testing, quantitation of furosemide in serum or plasma (b) Following an incident of bleeding that is confirmed will be performed; to be as a result of exercise induced pulmonary hemorrhage, (1/14/11) [Ch. 260-70 WAC—p. 7] 260-70-675 Equine Medication Program the horse, regardless of age, must be placed on the bleeder list name. The penalties for violation of this section are in WAC and is ineligible to race for the following time periods: 260-84-110. (i) First incident - fourteen days; (1) Class 1 (ii) Second incident within three hundred and sixty-five Class 1 drugs are stimulant and depressant drugs that day period - thirty days; have the highest potential to affect the performance of a (iii) Third incident within three hundred and sixty-five horse, and have no generally accepted medical use. Many of day period - one hundred and eighty days; these agents are Drug Enforcement Agency (DEA) Schedule (iv) Fourth incident within three hundred and sixty-five II substances. These include the following drugs and their day period - barred from racing for life. metabolites: Opiates, opium derivatives, synthetic opioids (c) For the purposes of counting the number of days a and psychoactive drugs, amphetamines and amphetamine- horse is ineligible to run, the day the horse bled externally is like drugs as well as related drugs, including but not limited the first day of the ineligibility period. to , nikethamide, mazindol, pemoline, and pen- (d) The voluntary administration of furosemide without tylenetetrazol. an external bleeding incident will not subject the horse to the initial period of ineligibility as defined by this policy. Drug Trade Name (e) Every horse that is confirmed a bleeder will have a Alfentanil Alfenta notation affixed to the horse's certificate of registration. Amphetamine (f) A horse may be removed from the bleeder list only Anileridine Leritine upon the direction of an official veterinarian. Apomorphine (3) A horse which has been placed on a furosemide or (BZP) bleeder list in another jurisdiction may be placed on the furo- Carfentanil semide list in this jurisdiction. Cathinone [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 660, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-660, filed Codeine 4/10/06, effective 5/11/06; 05-07-067, § 260-70-660, filed 3/11/05, effective DEA Schedule 1 (all) 4/11/05. Statutory Authority: RCW 67.16.020. 03-06-004, § 260-70-660, filed 2/20/03, effective 3/23/03. Statutory Authority: RCW 67.16.040. 96- Dextromoramide Palfium, Narcolo 10-001, § 260-70-660, filed 4/17/96, effective 5/18/96.] Diamorphine Donepezil Aricept WAC260-70-675 260-70-675 Bicarbonate testing. No bicarbon- Endorphins ate-containing substance or alkalizing substance that effec- Enkephalins tively alters the serum or plasma pH or concentration of Ethylmorphine Dionin bicarbonates or total in a horse may be admin- Etorphine HCl M99 istered to a horse within twenty-four hours of post time of the Fentanyl Sublimaze race in which the horse is entered. Heroin An official veterinarian, the board of stewards or the Hydrocodone (dihydrocodei- Hycodan executive secretary acting on behalf of the commission may none) at their discretion and at any time order the collection of test Hydromorphone Dilaudid samples from any horses either in the horse's stall or within Hydroxyamphetamine Paradrine the receiving or test barn to determine the serum or plasma Levo-Dremoran pH or concentration of bicarbonate, total carbon dioxide, or Lofentanil electrolytes. Mazindol Sanorex Test samples must not exceed 37.0 millimoles of total Meperidine Demerol carbon dioxide concentration per liter of serum or plasma. A Mephentermine Wyamine serum or plasma total carbon dioxide level exceeding this Aramine value is a violation of this rule. Penalties will be assessed as a Dolophine Class 4 violation as provided in WAC 260-84-110(6). Methamphetamine Desoxyn Split samples will be taken from all horses entered to run Methaqualone Quaalude in a race when bicarbonate testing is to be done. When split Methcathinone samples are taken, they will be shipped as soon as practical to Methylphenidate Ritalin the commission-approved laboratories for total carbon diox- Metopon (methyldihydromorphi- ide split sample testing. The commission is responsible for none) the cost of shipping and testing of split samples taken under Morphine this section. Nikethamide Coramine Oxycodone Percodan [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 675, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-675, filed Oxymorphone Numorphan 4/10/06, effective 5/11/06; 05-17-123, § 260-70-675, filed 8/18/05, effective Pemoline Cylert 9/18/05.] Pentylenetetrazol Metrazol, Nioric Phenazocine Narphen WAC260-70-680 260-70-680 Uniform classification guidelines. (PCP) Sernylan This section classifies each drug/medication/foreign sub- Phendimetrazine Bontril, etc. stance, and where appropriate and/or available, its trade Phenmetrazine Preludin [Ch. 260-70 WAC—p. 8] (1/14/11) Equine Medication Program 260-70-680

Drug Trade Name Drug Trade Name Picrotoxin Buspropion Wellbutrin Piritramide Butabarbital (Secbutobarbitone) Butacaps, Butasol, etc. Remifentanil Ultiva Butalbital (Talbutal) Fiorinal Strychnine Butanilicaine Hostacain Sufentanil Sufenta Repoise Butoctamide Listomin (2) Class 2 Caffeine Class 2 drugs are drugs/medication/foreign substances Camazepam Paxor that have a high potential to affect the performance of a horse, Captodiame Covatine but less of a potential than class 1 drugs. Class 2 drugs are Carbidopa + levodopa Sinemet either not generally accepted as therapeutic agents in racing Carbromol Mifudorm horses, or are therapeutic agents that have a high potential for Soma, Rela abuse. Carphenazine Proketazine Prazinil Drug Trade Name Carticaine (see ) Septocaine; Acecarbromal Ultracaine, etc. Tindal Chloralose (Alpha-Chloralose) Adinazolam Chloral betaine Beta-Chlor Alclofenac Chloral hydrate Nactec, Oridrate, etc. Alcuronium Alloferin Chloraldehyde (chloral) Alphaprodine Nisentil Chlordiazepoxide Librium Alpidem Anaxyl Chlormezanone Trancopal Alprazolam Xanax Althesin Saffan Chlorhexidol Amisulpride Solian Nesacaine Elavil, Amitril, Endep Chlorproethazine Newiplege Amobarbital Amytal Thorazine, Largactil Asendin Taractan Amperozide Citalopram Celex Anilopam Anisine Clobazam Urbanyl Aprobarbital Alurate Articaine Septocaine; Ultra- Clomethiazole caine, etc. Anafranil Strattera Clonazepam Klonopin Atracurium Tracrium Clorazepate Tranxene Azacylonol Frenque Clothiapine Entermin Azaperone Stresnil, Suicalm, Clotiazepam Trecalmo, Rize Fentaz (with Fentanyl) Cloxazolam Enadel, Sepazon, Barbital Veronal Tolestan Clozaril, Leponex Bemegride Megimide, Miked- Conorphone imide Corticaine Ultracain Benoxaprofen Crotetamide Benperidol Anquil Tercian Bentazepam Tiadipona Cyclobarbital Phanodorm Benzactizine Deprol, Bronchodil- Darbepoetin Aranesp etten Decamethonium Syncurine Demoxepam Benzodiazepines Norpromine, Benzphetamine Didrex Pertofrane Benztropine Cogentin Dezocine Dalgan® Biriperone Diazepam Valium Bromazepam Lexotan, Lectopam Dichloralphenazone Febenol, Isocom Bromisovalum Diffucord, etc. Diethylpropion Tepanil, etc. Parlodel Diethylthiambutene Themalon Bromperidol Bromidol Dihydrocodeine Parcodin Brotizolam Brotocol Dilorazepam Briantum Bupivacaine Marcaine Diprenorphine M50/50 Temgesic Dixyrazine Esucos Buspar Intropin (1/14/11) [Ch. 260-70 WAC—p. 9] 260-70-680 Equine Medication Program

Drug Trade Name Drug Trade Name Doxacurium Nuromax Isoproterenol Isoprel Doxapram Dopram Isoxicam Maxicam Doxefazepam Doxans Ketalar, Ketaset, Adapin, Sinequan Vetalar Droperidol Inapsine, Droleptan, Ketazolam Anxon, Laftram, Innovar-Vet (with Solatran, Loftran Fentanyl) Lenperone Elanone-V Lidocaine Xylocaine Epibatidine Lithium Lithizine, Duralith, Epinephrine etc. Erythropoietin (EPO) Epogen, Procrit, etc. Lobeline Estazolam Domnamid, Eurodin, Loflazepate, Ethyl Victan Nuctalon Imodium Ethamivan Loprazolam Dormonort, Havlane Ethanol Ativan Ethchlorvynol Placidyl Lormetazepam Noctamid Ethinamate Valmid Laxitane Ethopropazine Parsidol Ludiomil Ethylisobutrazine Diquel Mebutamate Axiten, Dormate, Duranest Capla Etifoxin Stresam Meclofenoxate Lucidiril, etc. Etizolam Depas, Pasaden Medazepam Nobrium, etc. Etodroxizine Indunox Eunerpan Etomidate Namenda Fenarbamate Tymium Meparfynol Oblivon Fenclozic Acid Cincopal Mepazine Pacatal Fenfluramine Pondimin Mephenoxalone Control, etc. Fluanisone Sedalande Mesantoin Fludiazepam Erispam Mephobarbital Mebaral Flunitrazepam Rohypnol, Narcozep, (Methylphenobarbital) Darkene, Hypnodorm Mepivacaine Carbocaine Fluopromazine Psyquil, Siquil Equanil, Miltown Fluoresone Caducid Serentil Prozac Metaclazepam Talis Flupenthixol Depixol, Fluanxol Metazocine Prolixin, Permitil, Metharbital Gemonil Anatensol Methohexital Brevital Flurazepam Dalmane Methotrimeprazine Levoprome, Neurocil, Fluspirilene Imap, Redeptin etc. Flutoprazepam Restas Methyprylon Noludar Fluvoxamine Dumirox, Faverin, etc. Metocurine Metubine Galantamine Reminyl Metomidate Hypnodil Gallamine Flaxedil Mexazolam Melex Midazolam Versed Glutethimide Doriden Mirtazepine Remeron Halazepam Paxipam Mivacurium Mivacron Haldol Modafinil Provigil Haloxazolam Somelin Molindone Moban Hemoglobin glutamers Oxyglobin, Hemopure Moperone Luvatren Hexafluorenium Myalexen Mosaprimine Hexobarbital Evipal Nalbuphine Nubain Homophenazine Pelvichthol Nalorphine Nalline, Lethidrone Atarax Serzone Ibomal Noctal Nimetazepam Erimin Imavate, Presamine, Nitrazepam Mogadon Tofranil Nordiazepam Calmday, Nordaz, etc. Isapirone Isocarboxazid Marplan Aventyl, Pamelor Isomethadone Olanzepine Zyprexa

[Ch. 260-70 WAC—p. 10] (1/14/11) Equine Medication Program 260-70-680

Drug Trade Name Drug Trade Name Oxazepam Serax Naropin Oxazolam Serenal Secobarbital (Quinalbarbitone) Seconal Oxyperitine Forit, Integrin Selegiline Eldepryl, Jumex Pancuronium Pavulon Sertraline Lustral, Zoloft Paraldehyde Paral Snake Venoms Paroxetine Paxil, Seroxat Somatrem Protropin Penfluridol Cyperon Somatropin Nutropin Nembutal Spiclomazine Taxilan Perfluorodecolin Succinylcholine Sucostrin, Quelin, etc. Perfluorodecahydronophthalene Sulfondiethylmethane Perfluorooctylbromide Sulfonmethane Perfluorotripropylamine Inofal Perfluorocarbons Sulpiride Aiglonyl, Sulpitil Alodept, etc. Sultopride Barnetil Hypnodin Talbutal Lotusate Trilafon Phenaglycodol Acalo, Alcamid, etc. Temazepam Restoril Phenelzine Nardelzine, Nardil Tetrabenazine Nitoman Luminal Pontocaine Phentermine Iomamin Tetrazepam Musaril, Myolastin Piminodine Alvodine, Cimadon Thebaine Orap Thialbarbital Kemithal Pinazepam Domar Thiamylal Surital Dipiperon Thiethylperazine Torecan Pipecuronium Arduan Thiopental Pentothal Pipequaline Dartal Piperacetazine Psymod, Quide Thioproperazine Majeptil Metycaine Mellaril Lonseren, Piportil Thiothixene Navane Pipradrol Dataril, Gerondyl, etc. Tiapride Italprid, Luxoben, etc. Piquindone Component of Telazol Prazepam Verstran, Centrax Timiperone Tolopelon Citanest Tofisopam Grandaxain, Seriel Darbazine, Compazine Topirimate Topamax Propanidid Ultram Propiomazine Largon Tranylcypromine Parnate Propionylpromazine Tranvet Desyrel Propiram Inolin Propofol Diprivan, Disoprivan Triazolam Halcion Ravocaine Tribromethanol Prothipendyl Dominal Tricaine methanesulfonate Finquel Concordin, Triptil Trichloroethanol Proxibarbital Axeen, Centralgol Tricholoethylene Trilene, Trimar Pyrithyldione Hybersulfan, Sonodor Triclofos Triclos Quazipam Doral Trifluomeprazine Nortran Seroquel Stelazine Racemethorphan Trifluperidol Triperidol Vetame, Vesprin Raclopride Surmontil Raylean Tubocurarine (Curare) Metubin Remoxipride Roxiam Tybamate Benvil, Nospan, etc. Reserpine Serpasil Urethane Rilmazafone Valdecoxib Nirvanyl Venlafaxine Effexor Rivastigmine Exelon Veralipride Accional, Veralipril Rocuronium Zemuron Vercuronium Norcuron Rofecoxib Vioxx Viloxazine Catatrol, Vivalan, etc. Sedivet Vinbarbital Delvinol

(1/14/11) [Ch. 260-70 WAC—p. 11] 260-70-680 Equine Medication Program

Drug Trade Name Drug Trade Name Vinylbital Optanox, Speda Cimeterol Clemastine Tavist Zaleplon Sonata Clenbuterol Ventipulmin Geodon Catapres Zolazepam Clostebol Zolpidem Ambien, Stilnox Cyclandelate Cyclospasmol Zomepirac Zomax Cycrimine Pagitane Zopiclone Imovan Danazol Danocrine Lodopin Dehydrochloromethyltestosterone Ciatyl, Cesordinol Deracoxib Deremaxx Desoxymethyltestosterone (3) Class 3 Dormosedan Class 3 drugs are drugs/medication/foreign substances Darvon that may or may not have generally accepted medical use in Diazoxide Proglycem the racing horse, but the pharmacology of which suggests less Diflunisal potential to affect performance than class 2 drugs. Dimefline Benadryl Drug Trade Name Dipyridamole Persantine Sectral Divalproex Depakote Acepromazine Atrovet, Notensil, Dobutrex PromAce® Albuterol () Proventil, Ventolin Doxylamine Decapryn Almotriptan Axert Dyphylline Edrophonium Tensilon Ambenonium Mytelase, Myeuran Eletripan Relpax Aminophylline Aminophyllin, etc. Enalapril (metabolite enaloprilat) Vasotec Mitaban mesylates Norvasc Erthrityl tetranitrate Cardilate Amyl nitrite Esmolol Brevibloc Arecoline Etamiphylline Tenormin Ethacrynic Acid Edecrin Atropine Zarontin Benazeprilat, Benazepril and Lotensin Ethylestrenol Maxibolin, Organon MC-Tab Ethylnorepinephrine Bronkephrine Kerlone Etodolac Lodine Bethanidine Esbatal Felbatol Biperiden Akineton Fenbufen Cincopal Zebeta, Bisobloc, Fenoldopam Corlopam etc. Fenoprofen Nalfon Effectin Berotec Bolasterone Respiride, Respan, Boldione etc. Bretylol Fentiazac Alphagan Flurbiprofen Froben Bromfenac Duract Bromodiphenhydramine Fluoxymesterone Halotestin Bufexamac Katadolone Bumex Formebolone Butorphanol Stadol, Torbugesic Altram Calusterone Fosinopril, Fosinoprilat Monopril Candesartan Atacand Cerebyx Captopril Capolen Furazabol Carbacel, Conduc- Neurontin ton Gestrinone Lentin, Doryl Glycopyrrolate Robinul Carbamezapine Tegretol Guanadrel Hylorel Carbinoxamine Clistin Ismelin Cartrol Wytensin Coreg Heptaminol Corofundol Celecoxib Celebrex Homatropine Homapin [Ch. 260-70 WAC—p. 12] (1/14/11) Equine Medication Program 260-70-680

Drug Trade Name Drug Trade Name Apresoline Norclostebol 4-Hydroxytestosterone Norethandrolone Corvert Nylidrine Arlidin Iloprost Ventavis Olmesartan Benicar Indomethacin Indocin Oxabolone Ipratropium Oxandrolone Anavar Irbesarten Avapro Trileptal Isoetharine Bronkosol Trasicor Isosorbide dinitrate Isordil Oxymesterone Kebuzone Oxymetholone Adroyd, Anadrol Ketorolac Toradol Papaverine Pavagen, etc. Normodyne Paradione Lamictal Pargyline Eutonyl Betagan Levatol Lisinopril Prinivil, Zestril Pentaerythritol tetranitrate Duotrate Losartan Hyzaar Pentazocine Talwin Mabuterol Perindopril Biprel Mecamylamine Inversine Dibenzyline Domitor Regitine Ponstel Isophrin, Mestanolone Neo- Mesterolone Propadrine Metaproterenol Alupent, Metaprel Physostigmine Eserine Metenolone Viskin Methachloline Maxair Methandienone Arelix, Tauliz Methandriol Probolic Piroxicam Feldene Methasterone Minipress Methixene Trest Mysoline Vasoxyl Procaine Orthoxide Pro Air Methsuximide Celontin Procyclidine Kemadrin Methylatropine Promazine Sparine Methyldienolone Phenergan Aldomet Propentophylline Karsivan Methylnortestosterone Inderal Methyltestosterone Metandren Prostanazol Methyl-1-testosterone Ventaire Metolazone Cenafed, Novafed Lopressor Pyridostigmine Mestinon, Regonol Posicor Pyrilamine Neoantergan, Mibolerone Equihist Pro-Amiline Quinapril, Quinaprilat Accupril Loniten Quinbolone Moexipril (metabolite moexiprilat) Uniretic Ramipril, metabolite Ramiprilat Altace Muscarine Yutopar Namumetone Anthraxan, Relafen, Rizatriptan Maxalt Reflifex Nadol Corgard Scopolamine (Hyoscine) Triptone Naloxone Narcan Sibutramine Meridia Naltrexone Revia Sildenafil Viagra Naratriptan Amerge Betapace, Sotacor Spirapril, metabolite Spiraprilat Renomax Neostigmine Prostigmine Stenbolone Nifluril Sulindac Clinoril Sumatriptan Imitrex Nitroglycerin Tadalasil Cialis 19-Norandrostenediol Telmisartin Micardis 19-Norandrostenedione Tenoxicam Alganex, etc. Norbolethone Tepoxalin

(1/14/11) [Ch. 260-70 WAC—p. 13] 260-70-680 Equine Medication Program

Drug Trade Name Drug Trade Name Hytrin Benzocaine Brethine, Bricanyl Benzthiazide Testolactone Teslac Bepadin Tetrahydrogestrinone Betamethasone Betasone, etc. Theophylline Aqualphyllin, etc. Bethanechol Urecholine, Duvoid Tiaprofenic Acid Surgam Boldenone Equipoise Blocardrin Bromhexine Oletor, etc. Priscoline Brompheniramine Dimetane, Disomer Tolmetin Tolectin Budesonide Pulmacort, Rhinocort Torsemide (Torasemide) Demadex Butyn Trandolapril (and metabolite, Tarka (butyl Butesin Trandolaprilat) aminobenzoate) Trenbolone Finoplix Butoxycaine Stadacain Trihexylphenidyl Artane Camphor Tridione Carprofen Rimadyl Trimethaphan Arfonad Cetirizine Zyrtec Tripelennamine PBZ Chlormerodrin Neohydrin Valerenic Acid Chlorophenesin Maolate Valsartan Diovan Chloroquine Avloclor Vardenafil Levitra Chlorothiazide Diuril Rompun, Bay Va Chlorpheniramine Chlortriemton, etc. 1470 Chlorthalidone Hydroton Zolmitriptan Zomig Paraflex Zonegran Nupercaine Δ-1-androstene-3, 17-diol Clanobutin Δ-1-androstene-3, 17-dione Clibucaine Batrax Δ-1-dihydrotestosterone Clidinium Quarezan, Clindex, etc. Clobetasol Temovate (4) Class 4 Clocortolone Cloderm Class 4 drugs include therapeutic drugs/medications/for- Clofenamide eign substances that would be expected to have less potential Clormecaine Placacid to affect the performance of a racing horse than class 3 drugs. Colchicine Cortisone Cortone, etc. Drug Trade Name Cyclizine Merazine Acetaminophen (Paracetamol) Tylenol, Tempra, etc. Flexeril Acetanilid Cyclomethylcaine Surfacaine Acetazolamide Diamox, Vetamox Anhydron, Renazide Acetophenetidin (Phenacetin) Periactin Acetylsalicylic acid () Dantrolene Dantrium Aclomethasone Aclovate Dembroxol (Dembrexine) Sputolysin Aldosterone Aldocortin, Electrocortin Deoxycorticosterone Percortin, DOCA, Ambroxol Ambril, etc. Descotone, Dorcostrin Amcinonide Cyclocort Desonite Des Owen Moduretic; Midamor Desoximetasone Topicort Aminocaproic Acid Amicar, Caprocid Dexamethasone Azium, etc. Aminodarone 2-Aminoheptaine Tuamine Dibucaine Nupercainal, Cinchocaine Aminopyrine Dichlorphenamide Daramide Amisometradine Rolictron Diclofenac Voltaren, Voltarol Amlopidine Norvasc, Ammivin Diflorasone Florone, Maxiflor Amrinone Diflucortolone Flu-Cortinest, etc. Anisotropine Valpin Digitoxin Crystodigin Antipyrine Digoxin Lanoxin Apazone (Azapropazone) Rheumox Cardizem Lioresal Dimethisoquin Quotane Beclomethasone Propaderm Diphenoxylate Difenoxin, Lomotil Benazepril Lotrel Dipyrone Novin, Methampyrone Bendroflumethiazide Naturetin Norpace Benoxinate Dorsacaine Dromostanolone Drolban [Ch. 260-70 WAC—p. 14] (1/14/11) Equine Medication Program 260-70-680

Drug Trade Name Drug Trade Name Dyclonine Dyclone Metaxalone Skelaxin Eltenac Methandrostenolone Dianabol Ergonovine Ergotrate Methantheline Banthine Gynergen, Cafergot, etc. Methapyrilene Histadyl, etc. Etanercept Enbrel Methazolamide Naptazane Ethoheptazine Zactane Methdilazine Tacaryl Peganone Methocarbamol Robaxin Ethoxzolamide Cardrase, Ethamide Methotrexate Folex, Nexate, etc. Ethylaminobenzoate Semets, etc. Methscopolamine Pamine (Benzocaine) Methylchlorthiazide Enduron Plendil Methandrostenolone Dianabol Fexofenadine Allegra Methylergonovine Methergine Firocoxib Methylprednisolone Medrol Idalon Sansert Floctafenine Idalon, Idarac Metiamide Flucinolone Synalar, etc. Metoclopramide Reglan Fludrocortisone Alforone, etc. Mexilitine Mexilil Flumethasone Flucort, etc. Milrinone Flumethiazide Ademol Mometasone Elocon Sibelium Montelukast Singulair Flunisolide Bronilide, etc. Naepaine Amylsine Flunixin Banamine Nandrolone Nandrolin, Laurabolin, Fluocinolone Synalar Durabolin Fluocinonide Licon, Lidex Privine Fluorometholone FML Naproxen Equiproxen, Naprosyn Fluoroprednisolone Predef-2X Cardine Fluprednisolone Alphadrol Procardia Flurandrenolide Cordran Nemotop Fluticasone Flixonase, Flutide Norethandrone Guaifenesin (glycerol Gecolate Nortestosterone Nemotop guiacolate) Olsalazine Dipentum Halcinonide Halog Norlfex Halobetasol Ultravate Oxaprozin Daypro, Deflam Hexocyclium Tral Afrin Cyclaine Oxyphenbutazone Tandearil Hydrochlorthiazide Hydrodiuril Oxyphencyclimine Daricon Hydrocortisone (Cortisol) Cortef, etc. Oxyphenonium Antrenyl Hydroflumethiazide Saluron Paramethasone Haldrone Motrin, Advil, Nurpin Pentoxyfylline Trental, Vazofirin [Nuprin], etc. Phenurone Infliximab Remicade Milontin Isoflupredone Predef Phenylbutazone Octin, Octon Dilantin Isopropamide Darbid Polythiazide Renese Vasodilan Pramoxine Tronothaine DynaCirc Prednisolone Delta-Cortef, etc. Ketoprofen Orudis Prednisone Meticorten, etc. Letosteine Viscotiol, Visiotal Probenecid Loratidine Claritin Pronestyl Antivert, Bonine Rythmol Arquel Propantheline Pro-Banthine Medrysone Medriusar, etc. Proparacaine Ophthaine Meloxicam Mobic Propylhexedrine Benzedrex Mepenzolate Cantil Quinidex, Quinicardine Mephenesin Tolserol Salicylamide Meralluride Mercuhydrin Salicylate Merbaphen Novasural Spironalactone Aldactone Mercaptomerin Thiomerin Stanozolol Winstrol-V Mercumalilin Cumertilin Sulfasalazine Azulfidine, Azaline Mersalyl Salyrgan Seldane, Triludan

(1/14/11) [Ch. 260-70 WAC—p. 15] 260-70-710 Equine Medication Program

Drug Trade Name effective 4/8/07; 06-09-009, § 260-70-680, filed 4/10/06, effective 5/11/06; Testosterone 05-07-067, § 260-70-680, filed 3/11/05, effective 4/11/05. Statutory Author- ity: RCW 67.16.040. 96-10-001, § 260-70-680, filed 4/17/96, effective Tetrahydrozoline Tyzine 5/18/96.] Theobromine Thiosalicylate WAC260-70-710 260-70-710 Voiding track record. In the event Thiphenamil Trocinate that a horse establishes a track record in a race and if it later Tonocard develops that the chemical analysis of any sample taken indi- Tranexamic Acid cates the presence of any prohibited substances for which the Triamcinolone Vetalog, etc. purse is redistributed, then such track record shall be null and Dyrenium void. Trichlormethiazide Naqua, Naquasone [Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-710, filed Tridihexethyl Pathilon 4/17/96, effective 5/18/96.] Trimeprazine Temaril

Triprolidine Actidil 260-70-720 WAC 260-70-720 Posterior digital neurectomy. (1) Tuaminoheptane Tuamine No person may bring onto the grounds of a racing associa- Vedaprofen tion, or enter or cause to be entered in any race, or sell, offer Calan, Isoptin for sale, or act as an agent in the sale of any horse on the Otrivin grounds under the jurisdiction of the commission that has had Zafirlukast Accolate a posterior digital neurectomy performed, or has had any Zeranol Ralgro nerve removed from the leg of such horse, except as provided Zileuton Zyflo in this chapter. (5) Class 5 (2) A horse upon which a posterior digital neurectomy Class 5 drugs include those therapeutic medications for has been performed is eligible to race if the following condi- which concentration limits have generally been established tions are met: by racing jurisdictions as well as certain miscellaneous (a) Prior approval of an official veterinarian has been agents such as DMSO and other medications. obtained before the horse was brought onto the grounds of the racing association; Drug Trade Name (b) An official veterinarian is satisfied that the loss of Anisindione sensation to the horse due to the posterior digital neurectomy Cilostazol Pletal will not endanger the safety of the public and the participants Cimetidine Tagamet in racing and does not compromise the integrity of horse rac- Cromolyn Intel ing; Dicumarol Dicumarol (c) The racing secretary is notified of the posterior digital Dimethylsulfoxide (DMSO) Domoso neurectomy at the time the horse is admitted to the grounds of Dimethylsulphone (MSM) the racing association; and Diphenadione (d) The horse's registration or eligibility certificate has Esomeprazole Nexium been marked to indicate that a posterior digital neurectomy Famotidine Gaster, etc. was performed. Lansoprazole [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- Mesalamine Asacol 720, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-720, filed Misoprostel Cytotec 4/10/06, effective 5/11/06; 05-07-067, § 260-70-720, filed 3/11/05, effective Nedocromil Tilade 4/11/05. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-720, Nizatidine Axid filed 4/17/96, effective 5/18/96.] Omeprozole Prilosec, Losec 260-70-730 Pantoprazole Protonix WAC 260-70-730 Postmortem examination. (1) The Phenindione Hedulin commission may require a postmortem examination of any Phenprocoumon Liquamar horse that is injured on the grounds of a racing association Pirenzapine Gastrozepin during its scheduled race meet and training periods, while the Polyethylene glycol horse is in training or in competition and that subsequently Rabeprazole Aciphex expires or is destroyed, or any horse that expires while Ranitidine Zantac housed on the grounds. In proceeding with a postmortem Warfarin Coumadin, Coufarin examination the commission or its designee will coordinate with the trainer and/or owner to determine and address any (6) Nonclassified substances insurance requirements. Nonclassified substances are considered to have no (2) Trainers and owners must cooperate with such action effect on the physiology of a horse, except to improve nutri- as a condition of licensure. tion or treat or prevent infections or parasite infestations. (3) An official veterinarian may take possession of the These substances normally include antimicrobials, antipara- horse upon death for postmortem examination. An official sitic drugs, and nutrients such as vitamins. veterinarian may submit blood, urine, other bodily fluid spec- [Statutory Authority: RCW 67.16.020 and 67.16.040. 08-03-046, § 260-70- imens or other tissue specimens collected during a postmor- 680, filed 1/10/08, effective 2/10/08; 07-07-012, § 260-70-680, filed 3/8/07, tem examination for analysis. Upon completion of the post- [Ch. 260-70 WAC—p. 16] (1/14/11) Equine Medication Program 260-70-730 mortem examination, the remains may be returned to the owner or disposed of at the owner's option. (4) The presence of a prohibited substance in a specimen collected during the postmortem examination may constitute a violation of these rules. (5) The cost of commission-ordered postmortem exami- nations, testing and disposal will be borne by the commis- sion. [Statutory Authority: RCW 67.16.020 and 67.16.040. 07-07-036, § 260-70- 730, filed 3/12/07, effective 4/12/07; 06-09-009, § 260-70-730, filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70-730, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-730, filed 4/17/96, effective 5/18/96.]

(1/14/11) [Ch. 260-70 WAC—p. 17]